Innovative nitric oxide delivery technology for postoperative pulmonary hypertension in congenital heart disease patients: a clinical trial

Innovative nitric oxide delivery technology for postoperative pulmonary hypertension in congenital heart disease patients: a clinical trial

Abstract Background Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator with therapeutic benefits for pulmonary hypertension patients. Traditional cylinder-based iNO delivery systems are costly and complex, creating unmet medical needs. This study evaluated the safety and efficacy of a n...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ruofan Liu, Yuntao Li, Bin Li, Shen Liu, Minghui Tong, Qiong Ma
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	BMC Cardiovascular Disorders
Subjects:	Electrochemical nitric oxide generator Congenital heart disease Pulmonary hypertension
Online Access:	https://doi.org/10.1186/s12872-025-04967-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn
by: Mei-Yin Lai, et al.
Published: (2018-02-01)

Evaluation of Plasma Nitric Oxide and Serum Endothelial Nitric Oxide Synthase in Pulmonary Hypertensive Dogs: A Clinical and Echocardiography Investigation
by: Siwayu Rattanakanokchai, et al.
Published: (2025-05-01)

Is Inducible Nitric Oxide Synthase (iNOS) Promising as a New Target Against Pulmonary Hypertension?
by: Piotr Ryszkiewicz, et al.
Published: (2025-03-01)

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)

INHALED NITRIC OXIDE: CLINICAL EFFECTS AND INFLUENCE ON THE PROFILE OF INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-12-01)

EFFICACY AND SAFETY OF INHALED NITRIC OXIDE USE IN PATIENTS WITH PULMONARY HYPERTENSION AND CHRONIC HEART FAILURE III-IV FUNCTIONAL CLASS, SURVIVED LEFT VENTRICULAR MYOCARDIAL INFARCTION: RESULTS OF NON-RANDOMIZED COMAPARIVE STUDY
by: P. N. Pavlenko, et al.
Published: (2014-07-01)

CLINICAL FEATURES OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL SYSTEMIC-TO-PULMONARYSHUNTS
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life
by: Tasnim Azad, et al.
Published: (2025-07-01)

Pharmacological test with sildenafil at pulmonary hypertension assessing in children with congenital heart diseases
by: O. S. Yanulevich, et al.
Published: (2010-10-01)

Calculation of hemodynamics by the Fick method in pulmonary hypertension associated with congenital heart defects
by: A. A. Shmalts, et al.
Published: (2022-05-01)

Pulmonary hypertension associated with congenital portosystemic shunts as a new form of portopulmonary hypertension in children and adults
by: I. M. Miklashevich, et al.
Published: (2024-04-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)
by: I. E. Chazova, et al.
Published: (2022-05-01)

Pulmonary arterial hypertension associated with congenital heart disease: lessons learnt from the large Turkish Nationwide Registry (THALES)
by: Serdar M. Kücükoglu, et al.
Published: (2021-07-01)

COMPARISON OF HEMODYNAMIC EFFECTS OF INHALATORY ILOPROST AND NITRIC OXIDE IN PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION
by: A. E. Bautin, et al.
Published: (2017-12-01)

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: NEW ASPECTS OF THE DEVELOPMENT AND PROGRESSION OF THE DISEASE
by: A. A. Klimenko, et al.
Published: (2014-07-01)

Pulmonary ultrasound-guided management of delayed pulmonary edema secondary to nitric acid fumes inhalation: a case report
by: Zhenqing Zhao, et al.
Published: (2025-07-01)

Impact of Phosphodiesterase-3 Inhibitor and Prostacyclin Analogue Combination on Pulmonary Hemodynamics in Acyanotic Congenital Heart Disease Patients with Pulmonary Hypertension: A Randomized Controlled Trial
by: Sefri Noventi Sofia, et al.
Published: (2025-06-01)

Maternal outcomes among pregnant women with shunt-related congenital heart disease-associated pulmonary hypertension: a retrospective study
by: Tiantian Sun, et al.
Published: (2025-07-01)

Mechanotransductive stabilization of HIF-1α is inhibited by mitochondrial antioxidant therapy in the setting of pulmonary overcirculation
by: Jason T. Boehme, et al.
Published: (2025-05-01)

COMPARATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH VARIOUS FORMS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE, ACCORDING TO THE CLINICAL CLASSIFICATION
by: S. E. Gratsianskaya, et al.
Published: (2019-12-01)

NITRIC OXIDE AND MYOCARDIAL REMODELING IN ARTERIAL HYPERTENSION IN AREAS OF HIGHER ALTITUDES
by: M. Kh. Kurdanova, et al.
Published: (2015-10-01)

Non-invasive ML methods for diagnosis of congenital heart disease associated with pulmonary arterial hypertension
by: Yuyang Gao, et al.
Published: (2025-01-01)

Postoperative systemic arterial hypertension in infants with congenital heart diseases: prevalence and risk factors
by: Xiaohong Chen, et al.
Published: (2025-12-01)

The features of expression of constitutive isoforms of the nitric oxide synthase in paraventricular and supraoptic nuclei of the hypothalamus in hypertension of different origins
by: Yu. M. Kolesnyk, et al.
Published: (2015-12-01)

Application of fractional exhaled nitric oxide and nasal nitric oxide in the evaluation of asthma control
by: Yucong Ma, et al.
Published: (2025-07-01)

Inhaled nitric oxide: are expectations justified?
by: I. A. Kozlov
Published: (2024-12-01)

Estimation of Nitric Oxide, Malondialdehyde, and Adenosine Deaminase in Serum of Hypertensive Patients and Normotensive Individuals in Erbil City
by: Gulzar I. Ibrahim, et al.
Published: (2019-05-01)

The role of nitric oxide in nephroprotection during surgical correction of congenital heart disease in children (literature review)
by: P. V. Zinchuk, et al.
Published: (2024-12-01)

Effects of different nitric oxide synthases on pulmonary and systemic hemodynamics in hypoxic stress rat model
by: Huan Zhang, et al.
Published: (2025-02-01)

Multicentre, randomised controlled trial of physiological-based cord clamping versus immediate cord clamping in infants with a congenital diaphragmatic hernia (PinC): statistical analysis plan
by: Emily J. J. Horn-Oudshoorn, et al.
Published: (2024-03-01)

Basic therapy efficacy in children with pulmonary hypertension related to congenital heart defects: place of endothelial dysfunction and systemic inflammation markers
by: E. Yu. Emelyanchik, et al.
Published: (2016-10-01)

Inhaled nitric oxide therapy in preterm infants born before 34 weeks of gestation: a nationwide multicenter study
by: Rui-hua Ba, et al.
Published: (2025-07-01)

Features of the inducible nitric oxide synthase expression in paraventricular and supraoptic nuclei of hypothalamus in different models of arterial hypertension
by: Yu. M. Kolesnyk, et al.
Published: (2016-08-01)

Analysis of exhaled nitric oxide and its influencing factors in patients with chronic obstructive pulmonary disease
by: Ya Shen, et al.
Published: (2025-07-01)

Pulmonary arterial hypertension associated with type II Abernethy malformation in an adolescent: a case report
by: I. M. Miklashevich, et al.
Published: (2024-03-01)

Contemporary survival outcomes of congenital systemic-to-pulmonary shunt in children with borderline pulmonary vascular resistant index compared to Eisenmenger syndrome
by: Nalin Chaiwangyen, et al.
Published: (2024-07-01)

Congenital Chylothorax and Congenital Pulmonary Airway Malformation: Case Report and Literature Review
by: Andréa L. Corso, et al.
Published: (2025-06-01)

Studying the possibilities of pharmacological correction of hypoxia-induced pulmonary hypertension using a phenolic compound with a laboratory cypher KUD975
by: L. V. Korokina
Published: (2024-01-01)

Balloon Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Lauren N. Carlozzi, et al.
Published: (2024-05-01)

INCREASED PULMONARY BLOOD FLOW IN NEWBORNS WITH CYANOTIC CONGENITAL HEART DEFECTS AND DUCTUS-DEPENDENT PULMONARY BLOOD FLOW: RESULTS AND FEATURES OF OUTPATIENT POSTOPERATIVE FOLLOW-UP
by: Anzhelika Mykhailovska, et al.
Published: (2024-10-01)